Sentences with phrase «current share prices for»

No, but it will download current share prices for some investments, so in some cases, current account values may be updated

Current share price for the whole of Dole is $ 10.70 per share, a 29 % margin of safety.

For example, if the current share price for a given stock is $ 100.00 and there are 10 shares outstanding for the corporation, then the market capitalization for the corporation would be $ 1,000.00.

For example, if the current share price for a security is $ 100.00 and the current bid price is $ 100.05, an investor will have to pay $ 100.05 for each share.

Not exact matches

Listed Perth company AnaeCo has announced plans for a $ 21.4 million rights issue pitched at lesss than half its current share price, as it seeks to complete its first waste treatment plant in Shenton

As new financial details are revealed, Uber's shareholders must consider whether to sell shares at the current $ 32.97 - per - share price that SoftBank has offered, or wait for a potential public offering in 2019.

The lot size rule for Japan shares makes it hard for Nintendo to widen the base of investors at the current price, says Atul Goyal of Jefferies.

For instance, a company may give an employee the right to buy 100 shares at the current price of $ 10 per share in 1998.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

So likely the most important factor weighing on investors, and Sprint's share price, is the concern that the merger will happen but without any bounty for current shareholders.

The second rule of thumb relates to our current fuel derivative portfolio where a 10 % reduction in the price of Brent for the remaining half of 2012 would result in an additional $ 0.04 of realized losses on fuel derivatives that would offset the $ 0.13 per share favorable impact from the reduced price of fuel.

With virtually identical market capitalization (the price it would take to buy all shares of a company's outstanding common stock at the current market value), what exactly is an investor in each respective firm getting for his or her money?

The company in August sold 1.5 million unregistered shares to a private investor who is also a current shareholder at a price of $ 2.10 per share, for aggregate consideration of $ 3.15 million.

At its current valuation of ~ $ 67 / share, HLF has a price to economic book value ratio (price - to - EBV) of 1.2 That ratio means that the market expects only 20 % growth in NOPAT for the remainder of HLF's existence.

The Company's current offering price for its Shares, as well as other information, including information about management and the healthcare - focused investment strategy, are available at http://www.nexpointcapital.com/.

In order to justify its current price of $ 31 / share, the company would need to grow NOPAT by 15 % compounded annually for the next 5 years.

To justify the current price of $ 47 / share, Jarden must grow NOPAT by 13 % compounded annually for the next 16 years, at which point, Jarden would be generating over $ 66 billion in revenue.

In 2002, Bezos did give his shares worth $ 500 million at current prices for charitable missions.

Price - to - earnings: the ratio for valuing a company that measures its current share price relative to its per - share earnPrice - to - earnings: the ratio for valuing a company that measures its current share price relative to its per - share earnprice relative to its per - share earnings.

The ratio for valuing a company that measures its current share price relative to its per - share earnings.

As a result of these agreements, Retrophin paid out $ 2.8 million in cash and issued 11,000 Retrophin shares, and Shkreli diverted an additional 47,610 Retrophin shares for the benefit of himself and his MSMB Funds, resulting in a benefit to him and to them of more than $ 4.5 million (at current market prices).1

For example, when we put Amazon (AMZN) in the Danger Zone back in May 2013, we highlighted that the current stock price of $ 267 / share embedded the expectation that the company would grow profits by 25 % compounded annually for 25 yeaFor example, when we put Amazon (AMZN) in the Danger Zone back in May 2013, we highlighted that the current stock price of $ 267 / share embedded the expectation that the company would grow profits by 25 % compounded annually for 25 yeafor 25 years.

In a more neutral scenario, where OCLR's NOPAT margins compress to 17.5 % (from 21 % TTM) and it grows revenue by 5 % annually for 10 years, the stock is worth ~ $ 11 / share today — a 65 % premium to the current stock price.

The weighted harmonic average of current share price divided by the forecasted one year earnings per share for each security in the fund.

Returns at public offering price (after sales charge) for class A and class M shares reflect the current maximum initial sales charges of 5.75 % and 3.50 % for equity funds and Putnam Multi-Asset Absolute Return Fund, and 4.00 % and 3.25 % for income funds (1.00 % and 0.75 % for Putnam Floating Rate Income Fund, Putnam Absolute Return 100 Fund, Putnam Fixed Income Absolute Return Fund, and Putnam Short - Term Municipal Income Fund), respectively.

Because TRC's offer price is at a price below the current market price, Kraft Heinz recommends that stockholders not tender their shares (i.e., take no action) or, if they have already tendered shares, withdraw their shares by providing the written notice described in the TRC mini-tender offer documents prior to the expiration of the offer, currently scheduled for 12:01 a.m., New York City time, on Wednesday, December 14, 2016.

Brin's Class B shares don't trade and are valued using current market prices for the company's Class A shares.

«To illustrate the probable epilogue to the current bubble, we've calculated price targets for some of the glamour techs, based on current revenues per share, multiplied by the median price / revenue ratio over the bull market period 1991 - 1999.

Earlier this month, for example, Berkshire said it would provide a $ 1.5 billion line of credit and buy 40 million shares at a 30 % discount to current market pricing of troubled Canadian lender Home Capital Group.

RW: With the current interest in buying electric cars, plus more wind turbines being built and growing Chinese infrastructure, does this mean the fundamentals are falling into place for rising copper prices and copper company share values?

While this would be bad for current shareholders of the bank, a lower share price would translate into a higher dividend yield, holding all else equal.

For example, you have an equity position of 500 shares at a current stock price of $ 45.00.

A question for investors is whether a company's current share price accurately reflects the true underlying value of the business.

If Goodyear can grow NOPAT by just 3 % compounded annually for the next decade, the stock is worth $ 39 / share today — a 22 % upside from current prices.

If GOOGL's NOPAT margin expands to 23 % (based on Cowen's estimate of tax reform's impact) and the company can grow after - tax profit by 14 % compounded annually for the next decade, the stock is worth $ 1,520 / share today, a 41 % upside from the current price.

To justify the current price of $ 6 / share, Groupon must increase its pretax (NOPBT) margin from -0.3 % to 3 % and grow revenue at 20 % per year for the next 16 years.

The bigger problem for bulls is how much the current share price already implies Expedia's profits will grow.

Earnings Yield - an earnings yield is the earning per share for the past 12 months, divided by the current price per share, Earnings yield are reported in percentages for easy bond comparisons.

Common shares of the Funds are only available for purchase / sale on the NYSE at the current market price (NYSE - MKT for MFS California Municipal Fund).

For example, getting it at 10 % below fair value would require a price of $ 64 / share, or about $ 3 less than its current price.

The current stock price (~ $ 33 / share) implies over about 12 % growth in profits compounded annually for about 10 years.

It is calculated by dividing the current market price of a stock by the earnings per share estimate for the future period.

The company announced in August that it sold 1.5 million unregistered shares to a private investor who is also a current shareholder at a price of $ 2.10 per share, for aggregate consideration of $ 3.15 million.

Determined by dividing current stock price by common stockholder equity per share (book value), adjusted for stock splits.

From Investopedia, «The price - earnings ratio (P / E Ratio) is the ratio for valuing a company that measures its current share price relative to its per - share earnings.»

To justify its current price of $ 72 / share, the company must raise its pretax (NOPBT) margin from -16 % to 5 % and grow revenue by 31 % per year for the next 18 years.

To justify its current price of $ 37 / share, the company must raise its pretax (NOPBT) margin from -32 % to +5 % (similar to LinkedIn and Yelp) and grow revenue at 29 % per year for the next 17 years.

The price - earnings ratio (P / E ratio) is the ratio for valuing a company that measures its current share price relative to its per - share earnings.

If pre-tax margins fall to 2010 levels (5.7 %) and the company's NOPAT declines by 2 % compounded annually for the next five years, the stock is worth $ 75 / share today (99 % above the current price).

Were sales to increase to Mattel's peak NOPAT from 2013, all of a sudden Hasbro could pay more than double the current share price and still create value for its shareholders.